Clinical Trial Update: Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating minocycline for improving neurological outcomes after endovascular revascularization in acute ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Acute Ischemic Stroke | Phase 2 | Status: WITHDRAWN